VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts22142323
Avg. Estimate1.061.033.834.22
Low Estimate0.680.793.473.25
High Estimate1.261.244.055.24
Year Ago EPS0.610.761.953.83
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts19192223
Avg. Estimate869.44M851.99M3.04B3.57B
Low Estimate785.87M810.7M2.81B3.47B
High Estimate878.52M889.5M3.05B3.69B
Year Ago Sales622.63M638.88M2.17B3.04B
Sales Growth (year/est)39.60%33.40%40.00%17.30%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.0.530.630.751.02
EPS Actual0.610.760.941.09
Difference0.080.130.190.07
Surprise %15.10%20.60%25.30%6.90%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate1.061.033.834.22
7 Days Ago1.061.033.834.22
30 Days Ago1.061.013.844.13
60 Days Ago1.0613.824.24
90 Days Ago1.061.013.824.27
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days5255
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesVRTXIndustrySectorS&P 500
Current Qtr.73.80%N/AN/A0.05
Next Qtr.35.50%N/AN/A0.04
Current Year96.40%N/AN/A0.10
Next Year10.20%N/AN/A0.09
Next 5 Years (per annum)56.86%N/AN/A0.12
Past 5 Years (per annum)66.38%N/AN/AN/A